Adial Pharmaceuticals Targets $40B Addiction Market by Mark Eisenberg 13.02.2024 Adial Pharmaceuticals acquires patent for genetic diagnostic tool to identify patients who may respond well to their lead drug AD04, ...
Boosting Opioid Settlement Funds with Health IT Investment by Lilu Anderson 07.02.2024 The U.S. opioid crisis necessitates a strategic approach to allocating settlement funds for health IT infrastructure. Three recommendations include integrating ...